Vivacta Plans Large Scale Manufacture of Point-of-Care Cartridges
News Jan 11, 2012
Vivacta’s cartridges incorporate an innovative piezofilm sensor. Vivacta’s technology platform enables the development of next-generation point-of-care diagnostics and monitoring systems. The finger-prick tests provide lab-quality measurement of disease markers and drugs in whole-blood in under ten minutes.
To lead the new initiative, Vivacta has appointed Andrew Whittle as Process Engineering Manager. Mr Whittle was Operations Manager and Site Leader at ThermoFisher Scientificprior to his appointment and brings in-depth knowledge of establishing an IVD (in vitro diagnostics) manufacturing cell to Vivacta.
Dr Tim Carter, CEO, said, "The creation of our pilot facility in 2009 gave Vivacta the strategic advantage of being able to develop new tests on consistently manufactured materials and demonstrated to potential commercial partners the scaleability of our process. Now we see the need to establish executable plans for commercial-scale manufacturing and we are delighted that Andrew Whittle has agreed to join us and lead this effort”.
In recognition of her role in achieving ISO 13485:2003 compliance for Vivacta’s existing pilot facility and the importance of her work in quality management, Sonja Jones has been promoted to Director of Quality and Regulatory Affairs.
Potential Barcode Identified for a Form of Alcoholic Liver DiseaseNews
NIAAA-supported researchers have discovered that extracellular vesicles released by liver cells in a mouse model of alcoholic steatohepatitis contain a miRNA signature detectable in the blood.READ MORE
Precision NanoSystems to Host Nanomedicines SymposiumNews
Precision NanoSystems holds its second annual nanomedicines symposium called Nanomedicines that will discuss the latest developments in nanomedicine research.READ MORE